To evaluate the biological characteristics of IGLL1, three independent shRNAs (Table 1) were used to knockdown IGLL1 in two T-ALL cell lines (J-gamma1 and 6T-CEM). The gene discussed is IGLL1; the disease is acute lymphoblastic leukemia.